Jazz Pharmaceuticals (JAZZ) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.73% |
| Dec 31, 2025 | 7.98% |
| Sep 30, 2025 | -21.76% |
| Jun 30, 2025 | -40.45% |
| Mar 31, 2025 | 21.68% |
| Dec 31, 2024 | 25.51% |
| Sep 30, 2024 | 14.35% |
| Jun 30, 2024 | -0.48% |
| Mar 31, 2024 | -13.12% |
| Dec 31, 2023 | -7.92% |
| Sep 30, 2023 | -1.80% |
| Jun 30, 2023 | 0.57% |
| Mar 31, 2023 | 7.50% |
| Dec 31, 2022 | -31.05% |
| Sep 30, 2022 | -22.12% |
| Jun 30, 2022 | -12.32% |
| Mar 31, 2022 | -8.45% |
| Dec 31, 2021 | -21.49% |
| Sep 30, 2021 | -26.94% |
| Jun 30, 2021 | -19.26% |
| Mar 31, 2021 | 6.00% |
| Dec 31, 2020 | 10.22% |
| Sep 30, 2020 | 8.33% |
| Jun 30, 2020 | 5.26% |
| Mar 31, 2020 | -29.37% |
| Dec 31, 2019 | -13.96% |
| Sep 30, 2019 | 18.06% |
| Jun 30, 2019 | 22.42% |
| Mar 31, 2019 | 31.99% |
| Sep 30, 2018 | 13.42% |
| Jun 30, 2018 | 14.73% |
| Mar 31, 2018 | 5.19% |
| Dec 31, 2017 | 15.95% |
| Sep 30, 2017 | 9.35% |
| Jun 30, 2017 | 33.16% |
| Mar 31, 2017 | 30.67% |
| Dec 31, 2016 | 34.45% |
| Sep 30, 2016 | 32.23% |
| Jun 30, 2016 | 37.88% |
| Mar 31, 2016 | 39.91% |
| Dec 31, 2015 | 33.09% |
| Sep 30, 2015 | 55.55% |
| Jun 30, 2015 | 70.69% |